4 Aug 2008 07:00
RNS Number : 4371A
Akers Biosciences, Inc.
04 August 2008
Embargoed 0700hrs, 4 August 2008
Akers Biosciences, Inc.
Notice of First Half Results
Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, will be pleased to report financial results for the first six months to 30 June on Monday, 8 September 2008.
For further information please contact:
Thomas A. Nicolette
President & CEO
Tel. +1 856 848 8698
Ben Simons or Eleanor Williamson
M: Communications
Tel. +44 (0) 20 7153 1540
Alasdair Younie
Arbuthnot Securities Limited
Tel. +44 (0)20 7012 2139
This information is provided by RNS
The company news service from the London Stock Exchange
AKR.L (AKR)